These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9267792)

  • 1. A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians.
    Bennett CL; Chapman G; Elstein AS; Knight SJ; Nadler RB; Sharifi R; Kuzel T
    Eur Urol; 1997; 32 Suppl 3():86-8. PubMed ID: 9267792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment considerations for persons with metastatic prostate cancer: survival versus out-of-pocket costs.
    Matchar DB; McCrory DC; Bennett CL
    Urology; 1997 Feb; 49(2):218-24. PubMed ID: 9037283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of utilities for health states in early stage prostate cancer.
    Saigal CS; Gornbein J; Nease R; Litwin MS
    J Urol; 2001 Sep; 166(3):942-6. PubMed ID: 11490251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians.
    Calhoun EA; Fishman DA; Lurain JR; Welshman EE; Bennett CL
    Gynecol Oncol; 2004 Apr; 93(1):164-9. PubMed ID: 15047231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician-patient communication: a study on the observed behaviours of specialty physicians and the ways their patients perceive them.
    Ruiz-Moral R; Pérez Rodríguez E; Pérula de Torres LA; de la Torre J
    Patient Educ Couns; 2006 Dec; 64(1-3):242-8. PubMed ID: 16597495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of techniques for eliciting patient preferences in patients with benign prostatic hyperplasia.
    Schulz MW; Chen J; Woo HH; Keech M; Watson ME; Davey PJ
    J Urol; 2002 Jul; 168(1):155-9. PubMed ID: 12050512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of health state utilities and quality of life in patients with malignant esophageal Dysphagia.
    Wildi SM; Cox MH; Clark LL; Turner R; Hawes RH; Hoffman BJ; Wallace MB
    Am J Gastroenterol; 2004 Jun; 99(6):1044-9. PubMed ID: 15180723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of patient and spouse assessments of health related quality of life in men with metastatic prostate cancer.
    Sneeuw KC; Albertsen PC; Aaronson NK
    J Urol; 2001 Feb; 165(2):478-82. PubMed ID: 11176400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures.
    Knight SJ; Chmiel JS; Kuzel T; Sharp L; Albers M; Fine R; Moran EM; Nadler RB; Sharifi R; Bennett CL
    J Urol; 1998 Nov; 160(5):1765-9. PubMed ID: 9783948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?
    Korfage IJ; de Koning HJ; Habbema JD; Schröder FH; Essink-Bot ML
    BJU Int; 2007 Apr; 99(4):801-6. PubMed ID: 17233804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: results from the Scandinavian Prostate Cancer Group Study 5.
    Jønler M; Nielsen OS; Groenvold M; Hedlund PO; Damber L; Hedelin H; Waldén M;
    Scand J Urol Nephrol; 2005; 39(1):42-8. PubMed ID: 15764270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in health-related quality of life of prostate cancer patients based on stage of cancer.
    Rosenfeld B; Roth AJ; Gandhi S; Penson D
    Psychooncology; 2004 Nov; 13(11):800-7. PubMed ID: 15386638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer.
    Bacon CG; Giovannucci E; Testa M; Kawachi I
    J Urol; 2001 Nov; 166(5):1804-10. PubMed ID: 11586228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and prostate cancer treatment: decision-making and rehabilitative support.
    Ritvo PG
    Can J Oncol; 1994 Nov; 4 Suppl 1():43-5; discussion 46. PubMed ID: 8853489
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluating a decision aid for patients with localized prostate cancer in clinical practice.
    Isebaert S; Van Audenhove C; Haustermans K; Junius S; Joniau S; De Ridder K; Van Poppel H
    Urol Int; 2008; 81(4):383-8. PubMed ID: 19077396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility assessment among patients with dry eye disease.
    Schiffman RM; Walt JG; Jacobsen G; Doyle JJ; Lebovics G; Sumner W
    Ophthalmology; 2003 Jul; 110(7):1412-9. PubMed ID: 12867401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient preferences for outcomes associated with surgical management of prostate cancer.
    Smith DS; Krygiel J; Nease RF; Sumner W; Catalona WJ
    J Urol; 2002 May; 167(5):2117-22. PubMed ID: 11956454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differing perceptions of quality of life in patients with prostate cancer and their doctors.
    Sonn GA; Sadetsky N; Presti JC; Litwin MS
    J Urol; 2009 Nov; 182(5):2296-302. PubMed ID: 19758610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.